Previous Article | Next Article 
Molecular and Cellular Biology, July 2001, p. 4119-4128, Vol. 21, No. 13
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.13.4119-4128.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Loss of Annexin A7 Leads to Alterations in
Frequency-Induced Shortening of Isolated Murine
Cardiomyocytes
Claudia
Herr,1
Neil
Smyth,2
Susanne
Ullrich,3
Fan
Yun,3
Phillip
Sasse,3
Jürgen
Hescheler,3
Bernd
Fleischmann,3
Katrin
Lasek,4
Klara
Brixius,4
Robert H. G.
Schwinger,4
Reinhard
Fässler,5
Rolf
Schröder,6 and
Angelika A.
Noegel1,*
Institute of Biochemistry
I1 and II,2
Department of Neurophysiology,3 and
Laboratory of Muscle Research and Molecular Cardiology, Clinic
III of Internal Medicine,4 University of
Cologne, 50931 Cologne, and Department of Neurology, University
Hospital Bonn, Bonn,6 Germany, and
Department of Experimental Pathology, Lund University,
Lund, Sweden5
Received 21 December 2000/Returned for modification 1 February
2001/Accepted 6 April 2001
 |
ABSTRACT |
Annexin A7 has been proposed to function in the fusion of vesicles,
acting as a Ca2+ channel and as Ca2+-activated
GTPase, thus inducing Ca2+/GTP-dependent secretory events.
To understand the function of annexin A7, we have performed targeted
disruption of the Anxa7 gene in mice. Matings between
heterozygous mice produced offspring showing a normal Mendelian pattern
of inheritance, indicating that the loss of annexin A7 did not
interfere with viability in utero. Mice lacking annexin A7
showed no obvious phenotype and were fertile. To assay for exocytosis,
insulin secretion from isolated islets of Langerhans was examined.
Ca2+-induced and cyclic AMP-mediated potentiation of
insulin secretion was unchanged in the absence of annexin A7,
suggesting that it is not directly implicated in vesicle fusion.
Ca2+ regulation studied in isolated cardiomyocytes, showed
that while cells from early embryos displayed intact Ca2+
homeostasis and expressed all of the components required for excitation-contraction coupling, cardiomyocytes from adult
Anxa7
/
mice exhibited an altered cell
shortening-frequency relationship when stimulated with high
frequencies. This suggests a function for annexin A7 in
electromechanical coupling, probably through Ca2+ homoeostasis.
 |
INTRODUCTION |
Annexins are a family of
Ca2+-and phospholipid-binding proteins encoded by at least
12 different genes in mammals and by numerous other genes in
invertebrates and plants. They are characterized by a bipartite
structure with a variable N-terminal domain and a conserved C-terminal
core. The latter is formed by either four- or eightfold repeats of
approximately 70 amino acids, each repeat carrying a
Ca2+-binding site. This C-terminal domain is also
responsible for phospholipid binding. The unique N-terminal regions are
thought to confer functional diversity (35). Although
annexins have been well characterized structurally and biochemically,
their cellular importance is unclear. Several roles have been proposed, such as the inhibition of phospholipase A2 and of blood coagulation (36, 48), the aggregation of chromaffin granules
(10), cross-linking functions in the cell cortex
(13), endo- and exocytosis (1, 11), as well
as functioning in the regulation and formation of ion channels
(18).
Annexin A7 (also called synexin), the first family member to be
described, was isolated as the agent that mediated aggregation of
chromaffin granules and fusion of membranes and phospholipids (8). Annexin A7 is unusual in that it carries a long
N-terminal extension of more than 100 amino acids. Alternative splicing
may lead to the inclusion of an extra exon in this region and leads to
the generation of two isoforms of 47 and 51 kDa. The 47-kDa protein is
present in all tissues except for skeletal muscle. Here the 47-kDa form
is lost upon myoblast differentiation, with the 51-kDa isoform being
exclusively present in myotubes (6, 38). Both forms are
expressed in the heart and brain (24, 38).
As with other family members, the function of annexin A7 remains
unclear. There are reports of it acting as a Ca2+ channel
and as Ca2+-activated GTPase, supporting
Ca2+/GTP-dependent secretion (5). Annexin A7
is found in the vicinity of secretory vesicles, on subcellular
membranous structures, and on plasma membranes (6, 22),
suggesting a possible role in Ca2+-mediated exocytosis.
However, in spite of these properties, it has been difficult to
unambiguously establish its function. Srivastava et al. recently
described an annexin A7 knockout mouse in which its absence resulted in
lethality at embryonic day (E10) due to cerebral hemorrhaging; further,
heterozygous mice had defects in inositol 1,4,5-triphosphate
(IP3) receptor expression, Ca2+ signaling, and
a lowered insulin content in the endocrine pancreas (39).
To describe further its in vivo function, annexin A7-deficient
(Anxa7
/
) mice were generated by homologous
recombination in embryonic stem (ES) cells. The resulting
Anxa7
/
mice are viable, are fertile, and
exhibit no differences from wild-type (WT) animals with respect to
insulin production and secretion. However, while no abnormalities in
Ca2+ homeostasis are seen at the early embryonic stage,
adult mice display defects in cardiomyocyte function.
 |
MATERIALS AND METHODS |
Construction of an Anxa7 targeting
construct.
An EMBL3 mouse genomic library of the 129SV mouse line
(46) was screened with a full-length mouse
Anxa7 cDNA as a probe. A 15-kb genomic fragment, containing
exons 4 to 13, was used to generate the targeting vector in pBluescript
SK. A MunI site in intron 4 was deleted by partial digestion
and religation. The sequences were then interrupted at the remaining
MunI site in exon 8 by insertion of the neomycin
resistance (neo) cassette from plasmid pPNT, resulting
in the targeting vector pM1P:BS. Exon 8-encoded amino acids are located
at the start of the annexin core domain. In this plasmid, the
neo cassette divided the Anxa7 fragment into two
arms, with 5 kb of homology in the 5' arm and 10 kb in the 3' arm. The
neo cassette was inserted so as to be transcribed in the
opposite orientation to the annexin A7 gene. Finally, plasmid pM1P:BS
was linearized with ClaI prior to transfection.
Anxa7 gene targeting in ES cells.
D3 mouse ES
cells (9) were grown in standard ES conditions with
Dulbecco modified Eagle medium supplemented with 15% fetal bovine
serum, 0.1 mM
-mercaptoethanol, and 1,000 U of leukemia inhibitory
factor (ESGRO; Life Technologies) per ml. Then 107 cells
were transfected by electroporation with 25 µg of linearized pM1P:BS,
and colonies were selected for resistance to G418 at 350 µg/ml in the
culture medium. Surviving clones were picked and expanded, and DNA was
extracted for Southern blot analysis. DNA from the cells was probed
with an external 5' probe and an internal 3' probe. In the case of
correct integration, the WT 13-kb EcoRI fragment was
increased to 15 kb.
Production of Anxa7
/
mice.
Two independent ES cell lines were used to generate germ line chimeras.
Blastocysts were isolated from C57BL/6 mice 3.5 days postcoitum and
were injected with 10 to 15 Anxa7+/
ES cells.
Blastocysts were then transferred into uteri of pseudopregnant foster
mothers. Chimeric male progeny were mated to C57BL/6 females, and
offspring were tested for germ line transmission by Southern blots of
DNA extracted from tail biopsies. Heterozygous animals were mated
together to establish a breeding colony.
Western blot and RNA analyses.
For Northern blot analysis,
total RNA was extracted from brain, heart, liver, and skeletal muscle
tissues with TRIzol reagent (Gibco-BRL). Then 30 µg of total RNA was
separated on a formaldehyde gel (1% agarose), transferred to a nylon
membrane (Biodyne; Pall), and probed with Anxa7 cDNA and the
neo cassette.
Gene expression studies were done using DNA microarrays (mouse Gem2;
Incyte Genomics, Palo Alto, Calif.). They were hybridized with poly(A)
RNA from heart, brain, and pancreas tissues of WT and
Anxa7
/
mice, and levels of annexins A1, A3
to A7, A10, and A11 were analyzed.
For Western blot analysis, cell extracts prepared from brain, heart,
liver, pancreas, and skeletal muscle tissues were electrophoresed
in a
sodium dodecyl sulfate (SDS)-12% polyacrylamide gel and transferred
onto nitrocellulose (Schleicher & Schuell, Dassel, Germany). Membranes
were probed as described previously (
6) with antibodies
against
annexins A1 (mouse monoclonal antibodies), A2 (rabbit
polyclonal
sera), A6 (sheep polyclonal sera) (all kindly provided by V. Gerke),
A5 (mouse monoclonal antibodies; kindly provided by M. Kawaminami),
A11 (human autoantibody sera, kindly provided by W. van
Venrooij),
and A7 (mouse monoclonal antibodies 203-217 and 203-80,
detecting
different epitopes) (
38) and a polyclonal rabbit
anti-annexin
A7 serum raised against the recombinant full-length
protein. Protein
bands were detected by
chemiluminescence.
Two-dimensional gel electrophoresis.
Protein separation was
carried out by two-dimensional gel electrophoresis (14,
28). Briefly, tissue samples were homogenized in lysis buffer
and centrifuged (100,000 × g, 1 h). For Western blot analysis, 200 µg of total protein was applied on Immobiline DryStrips (pH 3 to 10; Pharmacia) by in-gel rehydration. The first dimension was run on a Multiphor chamber (Pharmacia) for 10,000 V
· h. Separation in the second dimension was carried out in an SDS-12% polyacrylamide gel; proteins were then transferred to nitrocellulose and probed as described previously (6).
Histological analysis.
For general histological analysis,
organs were dissected, fixed in paraformaldehyde, embedded in paraffin,
and sectioned at 7 µm. Sections were then stained with hematoxylin
and eosin. Muscles were frozen in liquid nitrogen-cooled isopentane and
sectioned at 7 µm. For microscopy, sections were stained either with
hematoxylin and eosin, with trichrome according to the method of
Gomori, with oil red, by the periodic acid-Schiff reaction, or for
different specific enzymes (cytochrome c oxidase, succinate
dehydrogenase, NADH, and alkaline phosphatase).
Cell dissociation of early embryonic cardiomyocytes.
Murine
embryos (E11.5 to E12.5) were obtained from
Anxa7
/
and control mice by using standard
superovulation protocols (12). Embryonic hearts were
dissected and enzymatically digested as described before
(20). Contracting cardiomyocytes were used in the
experiments described below.
Ca2+ imaging.
Ca2+ imaging
experiments were performed as described previously (21).
Briefly, isolated murine cardiomyocytes were incubated for 12 min in
the cell-permeable dye fura-2AM (2 µM; Molecular Probes, Eugene,
Oreg.) at 37°C and then washed for 5 min. Excitation light (340/380
nm) was applied using a monochromator at frequencies ranging from 2 to
5 Hz. The emitted fluorescence from the fura-2AM-loaded cells (>470
nm) was monitored using a charge-coupled device cooled camera (TILL
Photonics, Planegg, Germany). The emission data were analyzed using the
Vision software package (TILL Photonics). Results are displayed as
340/380 nm ratios after background subtraction. The extracellular
solution consisted of 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgSO4, 5 mM HEPES 5, and 10 mM glucose (pH 7.4, adjusted
with NaOH); the high-K+ solution consisted of 5 mM NaCl,
140 mM KCl, 2 mM CaCl2, 2 mM MgSO4, 5 mM HEPES,
10 mM glucose (pH 7.4, adjusted with KOH).
Electrophysiology.
Patch clamp recordings were performed as
described before (21). Briefly, cells were held in the
voltage-clamp or current-clamp mode using an EPC-9 amplifier (Heka,
Lambrecht, Germany). For the recording of Ca2+ current
(ICa), voltage-clamped cells were held at
50 mV, and trains of depolarizing pulses lasting 50 ms were applied to a test
potential of 0 mV at a frequency of 0.2 Hz. Current-voltage relationships were determined by applying 150-ms depolarizing voltage
steps from test potentials of
40 to 40 mV in 10-mV steps (holding
potential of
50 mV). Results are expressed as means ± standard
errors of the means (SEM). Statistical analysis was performed using
unpaired Student's t test, and a probability value of
<0.05 was considered significant. For current-clamp and ramp depolarization recordings, the internal solution consisted of 50 mM
KCl, 80 mM potassium aspartate, 1 mM MgCl2, 3 mM MgATP, 10 mM EGTA, and 10 mM HEPES (pH 7.4, adjusted with KOH), and the external
solution consisted of 140 mM NaCl, 5.4 mM KCl, 3.6 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 10 mM
glucose (pH 7.4, adjusted with NaOH). For voltage-clamp recordings, the
internal solution consisted of 120 mM CsCl, 3 mM MgCl2, 5 mM MgATP, 10 mM EGTA, and 5 mM HEPES 5) (pH 7.4, adjusted with CsOH),
and the external solution consisted of 120 mM NaCl, 5 mM KCl, 3.6 mM
CaCl2, 20 mM TEA-Cl, 1 mM MgCl2, and 10 mM
HEPES (pH 7.4, adjusted with TEAOH). Carbachol (CCh) and caffeine were
purchased from Sigma (Deisenhofen, Germany), dissolved in the
extracellular solution, and stored frozen at
20°C. Aliquots were
thawed immediately before use and diluted to the desired concentration
in the bath solution.
Isolation and preparation of adult cardiomyocytes.
Ventricular myocytes were prepared from 10- to 12-week-old WT
(n = 8) and Anxa7
/
(n = 7) mice. In brief, the heart was quickly excised,
and the aorta was cannulated to the base of a Langendorff column
(height, 1.0 m). After an initial 10-min perfusion period with
Ca2+-free Tyrode's solution (11.1 mM glucose, 10 mM
HEPES-NaOH, 5.8 mM KCl, 0.9 mM MgSO4, 0.4 mM
NaH2PO4, 0.5 mM KH2PO4,
140 mM NaCl [pH 7.1, 37°C]), the heart was perfused for 15 to 25 min with Ca2+-free Tyrode's solution containing
collagenase (type I; 1 mg/ml; Sigma). Ca2+ was added every
3 to 5 min to the solution until a final concentration of 100 µmol/liter was reached. To wash out the collagenase, hearts was
perfused for 10 min with a solution consisting of 30.0 mM KCl, 30.0 mM
KH2PO4, 50.0 mM glutamate, 20.0 mM taurine, 10 mM glucose, 0.5 mM EGTA, and 3 mM MgSO4 (pH 7.3, adjusted
with KOH). The ventricles were separated from the atria, and
ventricular cells were mechanically dispersed in the glutamate
solution. Myocytes were stored for 30 min at room temperature before use.
Measurement of cell contraction.
Experiments were performed
at 32°C in Tyrode's solution (2 mM CaCl2, 120 mM NaCl,
5.4 mM KCl, 1 mM MgCl2, 22.6 mM NaHCO3, 0.42 mM
NaH2PO4, 5 mM glucose, 0.3 mM ascorbic acid,
0.05 mM EDTA [pH 7.4, carbogen gassed]). Aliquots (400 µl) of the
cell suspension were placed on laminin-coated glass cover slips forming
the bottom of the chamber and allowed to adhere at room temperature.
Measurements were taken with an inverted microscope as previously
described (17).
Isolation and incubation of Langerhans islets.
After
isolation by collagenase digestion (1 mg/ml; Serva, Heidelberg,
Germany), purified islets were preincubated for 1 h at 37°C in
incubation buffer containing, per liter, 140 mmol of NaCl, 5.6 mmol of
KCl, 1.2 mmol of MgCl2, 2.6 mmol of CaCl2, 2.8 mmol of glucose, 10 mmol of HEPES (pH 7.4), and 5 g of bovine serum albumin (fraction V; Sigma). Thereafter, batches of 10 islets per
ml were incubated for 30 min at 37°C in the presence of test substances as indicated for each experiment. Insulin released into the
supernatant and the insulin content of the islets after acid-ethanol
(1.5%/75% [vol/vol]) extraction were measured by radioimmunoassay
as described previously (42).
For perfusion experiments, 100 islets were placed in a column
containing 200 mg of Biogel P-2 (Bio-Rad, Munich, Germany),
and
incubation buffer containing 2.8 mmol of glucose per liter
was
circulated over the column at 0.7 ml/min for 1 h at 37°C.
Incubation was started by adding the test substances at appropriate
concentrations, and samples were collected every minute. Results
are
presented as mean ± SEM. Statistical significance was determined
by Student's
t test for paired and unpaired observations.
The
level of statistical significance was set at a probability of
0.05.
 |
RESULTS |
Generation of Anxa7
/
mice.
D3 ES cells were electroporated with the targeting vector pM1P:BS (Fig.
1A). Ten of 700 G418-resistant ES cell
clones underwent homologous recombination at the Anxa7
locus, as determined by Southern blot analysis (data not shown).
Targeted cells were injected into host C57BL/6 blastocysts, which were
transferred into the uteri of pseudopregnant females. Resulting
chimeric animals were used to derive heterozygous offspring. These did
not display any obvious abnormalities in comparison to their WT
littermates.


View larger version (74K):
[in this window]
[in a new window]
|
FIG. 1.
Targeted inactivation of the Anxa7 gene. (A)
The murine Anxa7 gene (top) consists of 14 exons (black
bars), with exon 14 containing 3' untranslated sequences. Disruption of
Anxa7 was achieved by targeting the phosphoglycerate
kinase-neo cassette to exon 8 (targeting vector pM1B:BS).
Lines represent intronic sequences. EI, EcoRI, S,
SalI. (B) Southern blot analysis of mouse tail DNA digested
with EcoRI and analyzed using the 5' external probe ex2/3 or
neo probe. The external ex2/3 probe detects a 15-kb fragment
(targeted allele) or a 13-kb fragment (WT allele); the neo
probe detects the 15-kb targeted band. (C) Northern blot analysis of
different organs from WT and homozygous
Anxa7 / animals. Transcripts of 2.4 and 1.8 kb corresponding to the normal Anxa7 mRNAs are detected in
the WT samples; smaller transcripts of 1.9 and 1.5 kb are detected in
the knockout samples. The -actin control is shown below. (D) Western
blot analysis of homogenates from different organs from WT and
Anxa7 / mice with antibodies 203-217 and
203-80. Antibody 203-217 detects a 47-kDa protein in the liver of
Anxa7 / mice which could not be detected by
203-80. B, brain; H, heart; L, liver; P, pancreas; SM, skeletal muscle;
SP, spleen.
|
|
Anxa7
/
mice are viable and
fertile.
To examine whether homozygous mutant animals were viable,
we intercrossed heterozygotes and determined the genotypes of their offspring by Southern blot analysis. Mice homozygous for the
anxa7 mutation, with loss of the 13-kb WT band and the
appearance of a 15-kb band, were detected (Fig. 1B). Pups from 36 such
litters were genotyped in this way, and the ratio of +/+, +/
, and
/
mice (28%: 48%: 24%) reflected the predicted Mendelian ratios of 1:2:1 for nonlethal alleles. Homozygous
Anxa7
/
mice were indistinguishable from
their WT littermates on the basis of size, activity, fertility, or
aging. Interbred Anxa7
/
females produced
normal litter sizes.
As described previously (
24), Northern blot analysis
revealed two mRNAs of 2.4 and 1.8 kb in WT mice. The two transcripts
are due to different poly(A) signals and were detectable with
an N- and
a C-terminal cDNA
Anxa7 probe. In
Anxa7
/
mice, two mRNAs of 1.9 and 1.5 kb
were recognized by the C-terminal
probe (Fig.
1C). The N-terminal probe
hybridized to a 1-kb band,
also detected by the
neo probe
and representing a fusion of the
neo transcript and
N-terminal annexin A7 sequences (data not shown).
These different RNA
species were present in all tissues analyzed.
We performed also reverse
transcription-PCR with different primer
pairs for the N-terminal
region, the resistance cassette, and
the core domain and could amplify
a fragment representing an
Anxa7-neo hybrid sequence
composed of the N-terminal part of annexin A7
up to exon 7 and the
neo cassette. These data indicate that no
intact mRNA for
annexin A7 was formed in
Anxa7
/
mice. To
verify the absence of annexin A7 protein in homozygous
mice, we
examined brain, heart, pancreas, and skeletal muscle
tissues. Western
blot analysis of the tissues was performed by
using mouse monoclonal
antibodies or polyclonal sera. No annexin
A7 protein bands were
detected in these tissues in the homozygous
mutant mice, whereas strong
signals were present in the WT animals
(Fig.
1D). Unexpectedly, Western
blot analysis of liver homogenates
showed a 47-kDa protein in the
mutant mice. This protein was detected
by several monoclonal antibodies
and the polyclonal serum raised
against recombinant full-length annexin
A7. Further characterization
showed grossly different pIs (WT, 5.8;
Anxa7
/
, 8.9) and dissimilar behaviors in an
annexin purification scheme
(data not shown). It is therefore presumed
that this protein is
not identical to annexin A7 but rather a
liver-specific
protein.
Given the absence of a striking phenotype, the possibility that other
members of the annexin family might compensate for the
loss of annexin
A7 was investigated. As such compensation could
be reflected in altered
gene expression, the levels of annexins
A1, A2, A4, A5, A6, and A11,
the closest relative to annexin A7,
were studied by Western blotting of
liver, brain, heart, and skeletal
muscle protein from WT and mutant
mice. No significant differences
in the expression for any of these
annexins was detected (Fig.
2). These
data were also supported by gene expression studies
using DNA
microarrays, where significant differences in mRNA levels
were also not
seen.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of annexins in
Anxa7 / mice. Proteins from liver, skeletal
muscle, heart, and brain were resolved by SDS-12% polyacrylamide gel
electrophoresis and transferred to nitrocellulose membranes for Western
blotting. In all tissues of the knockout mice, expression patterns of
the different annexins were the same as in the WT animals.
|
|
To exclude morphological abnormalities in the organs of
Anxa7
/
mice, we performed histological
analysis of brain, heart, kidney,
liver, lung, spleen, and skeletal
muscle tissues from mutant animals
and their littermates at 8 weeks and
10 months of age. None of
the organs tested showed obvious
abnormalities. More detailed
analysis of skeletal muscle using
different functional stains
also revealed no differences (data not
shown).
Insulin secretion is unaffected in
Anxa7
/
mice.
Insulin secretion is
regulated by Ca2+-dependent mechanisms (34).
Since it has been suggested that annexin A7 mediates Ca2+-
and GTP-induced secretion, we tested the secretory behavior of
pancreatic Langerhans islets in Anxa7
/
mice.
The average insulin contents of 177.2 ± 16.4 ng/islet (n = 7) for WT mice and 171.8 ± 20.7 ng/islet (n = 7) for
Anxa7
/
mice were not significantly different
(Fig. 3A). To investigate the effects of
Ca2+, cyclic AMP (cAMP), and metabolism on insulin
secretion, isolated islets were stimulated by tolbutamide (100 µM),
forskolin (5 µM), and glucose (16.7 mM), respectively. Raising the
glucose concentration of the medium from 2 to 16.7 mM increased
secretion from islets of WT mice almost sevenfold, and that from islets
of Anxa7
/
mice ninefold (Fig. 3B). At 2 mM
glucose, insulin secretion was not increased by the addition of 5 µM
forskolin, while at high glucose (16.7 mM), forskolin potentiated
glucose-induced secretion twofold in islets of both WT and knockout
mice. Tolbutamide did not increase insulin secretion at 2 mM glucose
(Fig. 3B). These results reveal that exocytotic release of insulin
stimulated by Ca2+ and cAMP is not significantly altered by
the absence of annexin A7.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 3.
Insulin secretion in Anxa7 /
mice is normal. (A) Insulin content of WT and
Anxa7 / islets. Islets were isolated as
described in the text, insulin was extracted from 10 islets with
acid-ethanol overnight at 4°C, and insulin was measured by radio
immuno assay. Results are presented as mean ± SEM for 16 independent determinations. (B) Effects of glucose, forskolin, and
tolbutamide on insulin secretion in isolated islets of WT and
Anxa7 / mice. Insulin secretion was measured
as described above, and substances were added as indicated. Data are
presented as mean ± SEM for the number of observations as
indicated in each column. (C) Effects of adrenaline on insulin
secretion. (D and E) Effects of glucose and CCh in WT (D) and
Anxa7 / (E) islets. Perfusion was started
with a solution containing 2.8 mM glucose; CCh was added to a
concentration of 1 µmol/liter. Data are presented as mean ± SEM
from three independent experiments.
|
|
Receptor agonists, which modulate insulin secretion, were then tested.
The physiological inhibitor adrenaline (1 µM) inhibited
insulin
secretion to the same extent in the knockout and WT islets
(Fig.
3C).
CCh potentiates insulin secretion by activation of
phospholipase C,
resulting in the generation of diacylglycerol
and IP
3. CCh
(1 µM) was tested in the presence of glucose (16.7
mM) by perfusion
of 100 isolated islets (Fig.
3D). Glucose-induced
insulin secretion was
augmented by CCh in both WT and
Anxa7
/
mice,
but to a lesser degree in the latter (Fig.
3D). These observations
taken with those of Srivastava et al. (
39), who described
decreased
IP
3 receptor number and impaired increases of
intracellular Ca
2+ concentration ([Ca
2+]) in
response to CCh in their
Anxa7+/
mouse strain,
suggest that the diminished secretory response
to CCh is due to a
decreased number of IP
3 receptors.
Early embryonic cardiomyocytes of
Anxa7
/
mice display intact Ca2+
homeostasis.
To address the involvement of annexin A7 in the
regulation of cytosolic Ca2+, intracellular
Ca2+ homeostasis in isolated
Anxa7
/
cardiomyocytes was analyzed by
single-cell imaging techniques. To circumvent compensational effects,
the experiments were performed during early embryonic development
(E11.5 to E12.5). Embryonic cardiomyocytes are characterized by
spontaneous contractions accompanied by intracellular Ca2+
transients (41, 45). This feature was also observed in
Anxa7
/
cardiomyocytes (n = 30 derived from three mice) (Fig.
4A). The resting Ca2+ (ratio
of 0.78 ± 0.02) was of a range similar to that occurring in WT
cells (ratio of 0.94 ± 0.02, n = 16). Moreover,
similar values of peak Ca2+ concentration during the
spontaneous contractions were observed in
Anxa7
/
(ratio of 1.28 ± 0.047, n = 30) and WT (ratio of 1.63 ± 0.057, n = 16) cardiomyocytes, indicating intact
excitation-contraction coupling. Because of the important functional
role of ryanodine-sensitive Ca2+ stores for the heart,
their expression was assayed using the ryanodine receptor (RyR) agonist
caffeine (10 mM). Caffeine evoked Ca2+ transients in the
Anxa7
/
cardiomyocytes with a similar
amplitude (ratio of 1.69 ± 0.132, n = 7) as found
in WT cells (ratio of 1.7 ± 0.136, n = 7; Fig. 4C), supporting intact Ca2+ homeostasis and functional
expression of ryanodine-sensitive Ca2+ stores in
Anxa7
/
mice.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Ca2+ homeostasis in
Anxa7 / embryonic cardiomyocytes is intact.
(A) Embryonic Anxa7 / cardiomyocytes
displayed spontaneous contractile activity accompanied by
Ca2+ transients. Between the Ca2+ transients,
stable diastolic Ca2+ levels were observed. Changes in
Ca2+ are displayed as 340/380 nm. (B) Spontaneously beating
Anxa7 / embryonic cardiomoycytes responded to
depolarization of the membrane potential by elevating the extracellular
K+ concentration with an increase of Ca2+. (C)
Extracellular perfusion with the RyR agonist caffeine evoked a
transient Ca2+ increase in an embryonic
Anxa7 / cardiomyocyte. When the increase of
the caffeine-induced Ca2+ transient was measured in WT and
Anxa7 / cardiomyocytes, no significant
difference was noted.
|
|
To study the loss of annexin A7 upon Ca
2+-induced
Ca
2+ release (CICR), patch-clamp experiments were
performed.
Anxa7
/
cardiomyocytes displayed
normal action potentials (90% action
potential duration, 242.7 ± 43.7 [Fig.
5A]) with a maximum
diastolic
potential of 56.8 ± 1.7 mV (
n = 7),
suggesting the functional
expression of cardiac ion channels. This was
corroborated by voltage-clamp
experiments, where using ramp
depolarizations (from

100 to 50
mV, 150 ms) inward rectifier
(I
Kt), Na
+, and Ca
2+ as well as
outward rectifier K
+ currents could be detected (Fig.
5B,
n = 6). Because of the critical
role of L-type
I
Ca for heart function, their expression and hormonal
modulation were also analyzed. I
Ca densities evoked by
50-ms lasting
depolarizing voltage steps from an HP of

50 to 0 mV
were found
to be similar in
Anxa7
/
cardiomyocytes (14.1 ± 2.5 pA/pF,
n = 7 [Fig.
5C]) and WT cells
(17.4 ± 2 pA/pF,
n = 7). In
line with a normal buildup of intracellular
signaling cascades at the
early embryonic stage (
20), the muscarinergic
agonist CCh
(1 µM) depressed basal I
Ca by 51.7 ± 8%
(
n = 3) in
Anxa7
/
cardiomyocytes and by 47.3 ± 6% (
n = 3) in WT
cardiomyocytes.
This could also be observed in current-clamp
experiments, where
application of CCh resulted in a pronounced negative
chronotropic
effect, reversible upon washout (Fig.
5D and E,
n = 4). The CCh
action was not accompanied by
hyperpolarization of the membrane
potential, suggesting the effect of
CCh to be related to depression
of I
Ca (
21).
Taken together, these data demonstrate that the
components required for
EC coupling and its hormonal modulation
are expressed in
Anxa7
/
embryonic cardiomyocytes.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
Normal electrophysiological characteristics are found in
Anxa7 / embryonic cardiomyocytes. (A) An
early embryonic, spontaneously contracting
Anxa7 / ventricular cardiomyocyte displayed a
typical ventricular action potential. (B) By applying a 150-ms ramp
depolarization from 100 to 50 mV, the functional expression of
IKl, INa, ICa and IKout
was detected. (C) The current densities of ICa were similar
in WT and Anxa7 / cardiomyocytes. (D) A
representative Anxa7 / embryonic
cardiomyocyte responded to CCh application with a prominent depression
of basal ICa, which could be reversed by washout. (E) CCh
addition to a spontaneously contracting
Anxa7 / early embryonic ventricular
cardiomyocyte led to a halt of the electrical activity, accompanied by
a small depolarization of the membrane potential. The effect of CCh
could be reversed by washout.
|
|
Shortening-frequency relationship is altered in
Anxa7
/
mice.
The failure to observe
aberrations in the embryonic cardiomyocytes of
Anxa7
/
mice does not rule out changes in
cells from adult hearts, where mechanical and electrophysiological
stress is increased and the mechanisms for excitation-contraction more
differentiated. In particular, the T-tubular system is highly developed
in the adult cardiomyocyte. In most mammalian species, including mice,
an increase in the stimulation frequency is accompanied by an increase
in the contractile force (4). This is caused partly by a
frequency-induced increase in the intracellular systolic
Ca2+ concentration, possibly through a greater
Ca2+ release from sarcoplasmic reticulum (37)
or by an increased Ca2+ influx via ICa
(32). Differences in the regulation of the intracellular Ca2+ homeostasis can be examined by measuring changes in
cell shortening and diastolic cell length in isolated, ventricular
myocytes, electrically stimulated at increasing stimulation
frequencies. Under basal conditions (0.5 Hz), maximal cell shortening
was 2.3 ± 0.3 µm in Anxa7
/
mice
(n = 15 from three mice) and 1.8 ± 0.2 µm in
the control group (n = 14 from six mice) (Fig.
6). In controls, cell shortening was
increased when the frequency of stimulation was raised from 0.5 to 5 Hz
(2.3 ± 0.4 versus 7.7 ± 1.7 µm, n = 8
from four mice). In contrast, cell shortening declined at increasing
stimulation frequencies in Anxa7
/
mice
(2.8 ± 0.5 versus 0.9 ± 0.1 µm, n = 8
from two mice). Diastolic cell length did not change during the
experiments (0.5 versus 5.0 Hz; WT, 129 ± 10 versus 127 ± 10 µm; Anxa7
/
, 102 ± 10 versus
107 ± 14 µm) (Fig. 6).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 6.
Shortening-frequency relationship measured in single
cardiomyocytes from Anxa7 / (filled
triangles) and and WT (open triangles) mice. Shortening-frequency
relationship was impaired in the Anxa7 /
group. P < 0.05 versus
Anxa7 / .
|
|
To test whether annexin A7 is involved in the positive inotropic effect
induced by stimulation of the

-adrenergic receptor/adenylyl
cyclase
system, concentration responses to isoprenaline (0.1 to
3 µM) were
performed in isolated electrically (0.5 Hz) stimulated
ventricular
myocytes. The maximal isoprenaline-induced increase
in cell shortening
was not different between
Anxa7
/
mice and
their WT littermates (Table
1). In both
groups, diastolic
cell length remained stable during the experiments
(data not shown).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Influence of isoprenaline on cell shortening and
diastolic cell length in isolated ventricular murine cardiomyocytes
from Anxa7 / mice (n = 5 from
two mice) and controls (n = 3 from two mice)
|
|
 |
DISCUSSION |
The annexin A7 gene is not essential for mouse viability.
Although annexin A7 is expressed in almost every tissue and in
undifferentiated ES cells (C. Herr, unpublished data), mice lacking
this gene are viable, are fertile, and show no severe changes. The
results presented here differ from those recently reported
(39), where targeted disruption of the
Anxa7
/
gene resulted in an embryonic
lethality, and where heterozygous animals displayed a defect in
IP3 receptor expression, Ca2+ signaling, and
insulin secretion. The discrepancy could be due to differences in the
induced mutations. In the mouse lines described here, the
neo cassette was inserted directly into exon 8 of the annexin A7 gene, whereas Srivastava et al. replaced part of intron 5 and exon 6, an exon transcribed only in striated muscle and in the
brain (39). Further, the neo gene was oriented
differently in the two strains, being transcribed in the opposite
direction to Anxa7
/
in the mice described
here. Hence, the conflicting results might be due to alterations in the
expression of other genes in the vicinity of the integration site, as
demonstrated for the myogenic basic helix-loop-helix gene
MRF4 (31), where similar differences occurred
in knockout strains. One further variable could be the different
genetic backgrounds used, as has been seen for the gelsolin knockout
strain, which was viable on a mixed background but showed almost 100%
lethality when bred on a BALB/c or C57BL/6 background (23). It should be noted that the
Anxa7
/
mutation presented here has been bred
on 129SV and C57BL/6 backgrounds without a loss in viability (Herr,
unpublished data).
Having generated viable annexin A7-deficient mice, we could address
questions relating to annexin A7 function. Striated muscle
was studied
to reveal effects due to altered Ca
2+ homeostasis, while
Langerhans islets were used as a test system
for the analysis of
secretion. Overall, no obvious defects caused
by the loss of annexin A7
in the mice were observed. At a cellular
level, previous experiments
suggested that annexin A7 is required
as a Ca
2+/GTPase in
secretion events, as a Ca
2+ ion channel, or as an ion
channel regulator. We now conclude
that annexin A7 is not crucial for
these events. Our results do
not, however, preclude it having a
modulatory role in exocytosis
or secretion or in regulating
Ca
2+ homeostasis. It should be noted that while the annexin
A6-deficient
mouse also showed no obvious phenotype (
16),
overexpression
of this protein in the cardiomyocytes of transgenic mice
led to
cardiomyopathy and heart failure (
15), suggesting
that annexins
can play important modulatory roles. Hence, the lack of
an overt
phenotype in the absence of annexin A7 could reflect a subtle
function; it is also possible that another member of the 10 known
murine annexins could compensate for its absence. However, in
brain,
heart, liver, and skeletal muscle, none of the annexins
A1, A2, A4, A5,
A6, and A11 were obviously up- or down-regulated
at either the mRNA or
protein
level.
Annexin A7 is not required for insulin secretion.
Annexin A7
binds to phospholipids and hydrolyzes GTP in a
Ca2+-dependent manner (33). It also promotes
membrane aggregation in vitro, a prerequisite for exocytotic membrane
fusion (5). Ca2+- and GTP-dependent secretion
has been described in a variety of endocrine cells, including
chromaffin cells and insulin-secreting
cells (3, 43).
These findings suggested a regulatory role for annexin A7 during the
exocytotics in endocrine cells. However, here we show that annexin A7
is not essential for this process in insulin-secreting cells, since the
maximal insulin release was not significantly different from that in
the islets of Anxa7
/
mice compared to WT
mice. Also, the mechanisms for the modulation of exocytosis were not
impaired, as in both WT and Anxa7
/
islets,
the adrenalin response was induced by the interaction of the hormone
directly with the exocytotic fusion machinery as well as through
lowering cAMP and [Ca2+]i (42).
Further, the insulin content of isolated islets was not significantly
different in the Anxa7
/
mice compared to WT
littermate controls. In contrast, Srivastava et al. observed a
10-fold-larger insulin content and hyperplastic islets in their
Anxa7+/
mutant mice.
To examine the role of annexin A7 during IP
3-induced
mobilization of Ca
2+, the effect of CCh on insulin
secretion was assessed in
Anxa7
/
islet
cells. CCh-induced secretion was diminished but not abolished
in
knockout islets. In the
Anxa7+/
mice of
Srivastava et al., 10-fold fewer IP
3 receptors were
present,
and this was accompanied by a lower and slower increase in
[Ca
2+]
i compared to islets isolated from WT
mice. This loss of IP
3 receptors could be responsible for
the impaired release induced
by CCh. Indeed, the absence of the
IP
3 receptor in mice leads
to an unresponsiveness to
agonists acting through phospholipase
C (
40). As
IP
3 receptors have been found on secretory vesicles
as well
as IP
3-sensitive endoplasmic reticular membranes
(
47),
their interaction with annexin A7 may occur at the
secretory vesicles.
Thus, IP
3-induced Ca
2+
release may promote annexin A7-mediated membrane aggregation
and
fusion. Other members of the annexin family are found in rat

cells;
for instance, annexin A1 is located on the membrane of
insulin-containing granules and maybe involved in the regulation
of
glucose-induced insulin secretion (
29,
30), an event which
seems unaffected by the loss of annexin A7. Recently it was suggested
that annexin A11 plays a role in Ca
2+- or GTP

S-induced
insulin secretion (
19) and therefore may
compensate for
the loss of annexin A7. However, there was no alteration
in the levels
of annexin A11 in the mutant
mice.
Is annexin A7 involved in Ca2+ homeostasis of
cardiomyocytes?
The studies with early embryonic cardiomyocytes
clearly indicate intact Ca2+ homeostasis and expression of
the cellular components required for CICR; however, adult
Anxa7
/
cardiomyocytes exhibited a decrease
in frequency-induced cell shortening. This implies that the regulation
of electromechanical coupling at high systolic Ca2+
concentration is impaired and indicates that annexin A7 is involved in
the regulation of Ca2+ homeostasis and/or the function of
the contractile apparatus in the adult stage. The defect does not,
however, interfere with the viability of animals maintained under
normal conditions.
While a direct interaction between annexin A7 and myofilaments has not
been reported, it was shown recently that annexin A7
binds in a
Ca
2+-dependent manner to sorcin, a protein which
functionally interacts
with the Ca
2+ release channel of the
sarcoplasmic reticulum (RyR) (
44). Like
annexin A7, sorcin
translocates from the cytoplasm to the membrane
with increasing
intracellular Ca
2+ concentrations, and annexin A7 may
recruit sorcin to the plasma
membrane (
6,
27). Sorcin has
been suggested to mediate interchannel
communication between the L-type
Ca
2+ channels on the plasma membrane and RyR protein at the
sarcoplasmic
reticulum during excitation-contraction coupling in the
postnatal
cardiac muscle (
25,
26). This possibly explains
the intact
function of embryonic cardiomyocytes lacking annexin A7, as
the
contractile machinery in the immature rodent heart is activated
largely by Ca
2+ entering the cell directly through L-type
channels rather than
by RyR-mediated CICR (
2,
7). As the
T-tubule/sarcoplasmic
reticulum system gradually develops, contraction
becomes more
dependent on CICR (
7); hence, the decrease in
cell shortening
seen upon high-frequency stimulation in the
cardiomyocytes of
adult
Anxa7
/
mice may
result from impairment of the interaction between sorcin
and RyR.
Annexin A7's localization at the T-tubule system makes
it well suited
to modulate such an interaction (
38).
 |
ACKNOWLEDGMENTS |
We thank Stephan Selbert, Olaf Weiner, Regine Brokamp, and Jana
Köhler for help during the initial phase of this project, Andrea
Hufschmidt, Berthold Gassen, and Rolf Müller for skilled technical help, Volker Gerke, Mitsumori Kawaminami, Walther van Venrooij, and Carlotta Zamparelli for providing reagents, Walter Witke
for the genomic library, and Michael Schleicher for discussion.
S.U. is a recipient of a Heisenberg fellowship. This work was supported
by grants from the DFG and the Center for Molecular Medicine Cologne to
A.A.N.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Biochemistry I, Joseph-Stelzmann-Str. 52, 50931 Cologne, Germany.
Phone: 49 221 478 6980. Fax: 49 221 478 6979. E-mail:
noegel{at}uni-koeln.de.
 |
REFERENCES |
| 1.
|
Ali, S. M.,
M. J. Geisow, and R. D. Burgoyne.
1989.
A role for calpactin in calcium-dependent exocytosis in adrenal chromaffin cells.
Nature
340:313-315[CrossRef][Medline].
|
| 2.
|
Bers, D. M.,
L. Li,
H. Satoh, and E. McCall.
1998.
Factors that control sarcoplasmic reticulum calcium release in intact ventricular myocytes.
Ann. N. Y. Acad. Sci.
853:157-177[CrossRef][Medline].
|
| 3.
|
Bittner, M. A.,
R. W. Holz, and R. R. Neubig.
1986.
Guanine nucleotide effects on catecholamine secretion from digitonin-permeabilized adrenal chromaffin cells.
J. Biol. Chem.
261:10182-10188[Abstract/Free Full Text].
|
| 4.
|
Bowditch, H. P.
1871.
Über die Eigenthümlichkeit en der Reizbarkeit, welche die Muskelfasern des Herzens zeigen.
Ber. Verh. Saechs. Ges. (Akad.) Wiss.
23:652-689.
|
| 5.
|
Caohuy, H.,
M. Srivastava, and H. B. Pollard.
1996.
Membrane fusion protein synexin (annexin 7) as a Ca2+/GTP sensor in exocytotic secretion.
Proc. Natl. Acad. Sci. USA
93:10797-10802[Abstract/Free Full Text].
|
| 6.
|
Clemen, C. S.,
A. Hofmann,
C. Zamparelli, and A. A. Noegel.
1999.
Expression and localisation of annexin 7 (synexin) isoforms in differentiating myoblasts.
J. Muscle Res. Cell Motil.
20:669-679[CrossRef][Medline].
|
| 7.
|
Cohen, N. M., and W. J. Lederer.
1988.
Changes in the calcium current of rat heart ventricular myocytes during development.
J. Physiol. (London)
406:115-146[Abstract/Free Full Text].
|
| 8.
|
Creutz, C. E.,
C. J. Pazoles, and H. B. Pollard.
1978.
Identification and purification of an adrenal medullary protein (synexin) that causes calcium-dependent aggregation of isolated chromaffin granules.
J. Biol. Chem.
253:2858-2866[Free Full Text].
|
| 9.
|
Doetschman, T. C.,
H. Eistetter,
M. Katz,
W. Schmidt, and R. Kemler.
1985.
The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium.
J. Embryol. Exp. Morphol.
87:27-45[Medline].
|
| 10.
|
Drust, D. S., and C. E. Creutz.
1988.
Aggregation of chromaffin granules by calpactin at micromolar levels of calcium.
Nature
331:88-91[CrossRef][Medline].
|
| 11.
|
Emans, N.,
J. P. Gorvel,
C. Walter,
V. Gerke,
R. Kellner,
G. Griffiths, and J. Gruenberg.
1993.
Annexin II is a major component of fusogenic endosomal vesicles.
J. Cell Biol.
120:1357-1369[Abstract/Free Full Text].
|
| 12.
|
Fleischmann, M.,
W. Bloch,
E. Kolossov,
C. Andressen,
M. Muller,
G. Brem,
J. Hescheler,
K. Addicks, and B. K. Fleischmann.
1998.
Cardiac specific expression of the green fluorescent protein during early murine embryonic development.
FEBS Lett.
440:370-376[CrossRef][Medline].
|
| 13.
|
Glenney, J. R., Jr.
1987.
Calpactins: calcium-regulated membrane-skeletal proteins.
Biochem. Soc. Trans.
15:798-800[Medline].
|
| 14.
|
Görg, A.
1993.
Two-dimensional electrophoresis with immobilized pH gradients: current state.
Biochem. Soc. Trans.
21:130-132[Medline].
|
| 15.
|
Gunteski-Hamblin, A. M.,
G. Song,
R. A. Walsh,
M. Frenzke,
G. P. Boivin,
G. W. Dorn, 2nd,
M. A. Kaetzel,
N. D. Horseman, and J. R. Dedman.
1996.
Annexin VI overexpression targeted to heart alters cardiomyocyte function.
Am. J. Physiol.
270:H1091-H1100[Abstract/Free Full Text].
|
| 16.
|
Hawkins, T. E.,
J. Roes,
D. Rees,
J. Monkhouse, and S. E. Moss.
1999.
Immunological development and cardiovascular function are normal in annexin VI null mutant mice.
Mol. Cell. Biol.
19:8028-8032[Abstract/Free Full Text].
|
| 17.
|
Hoischen, S.,
K. Brixius, and R. H. Schwinger.
1998.
T- and L-type Ca2+-channel antagonists reduce contractility in guinea pig cardiac myocytes.
J. Cardiovasc. Pharmacol.
32:323-330[CrossRef][Medline].
|
| 18.
|
Huber, R.,
J. Römisch, and E. P. Paques.
1990.
The crystal and molecular structure of human annexin V, an anticoagulant that binds to calcium and membranes.
EMBO J.
9:3867-3874[Medline].
|
| 19.
|
Iino, S.,
T. Sudo,
T. Niwa,
T. Fukasawa,
H. Hidaka, and I. Niki.
2000.
Annexin XI may be involved in Ca2+- or GTP S-induced insulin secretion in the pancreatic beta-cell.
FEBS Lett.
479:46-50[CrossRef][Medline].
|
| 20.
|
Ji, G. J.,
B. K. Fleischmann,
W. Bloch,
M. Feelisch,
C. Andressen,
K. Addicks, and J. Hescheler.
1999.
Regulation of the L-type Ca2+ channel during cardiomyogenesis: switch from NO to adenylyl cyclase-mediated inhibition.
FASEB J.
13:313-324[Abstract/Free Full Text].
|
| 21.
|
Kolossov, E.,
B. K. Fleischmann,
Q. Liu,
W. Bloch,
S. Viatchenko-Karpinski,
O. Manzke,
G. J. Ji,
H. Bohlen,
K. Addicks, and J. Hescheler.
1998.
Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein.
J. Cell Biol.
143:2045-2056[Abstract/Free Full Text].
|
| 22.
|
Kuijpers, G. A.,
G. Lee, and H. B. Pollard.
1992.
Immunolocalization of synexin (annexin 7) in adrenal chromaffin granules and chromaffin cells: evidence for a dynamic role in the secretory process.
Cell Tissue Res.
269:323-330[CrossRef][Medline].
|
| 23.
|
Kwiatkowski, D. J.
1999.
Functions of gelsolin: motility, signaling, apoptosis, cancer.
Curr. Opin. Cell Biol.
11:103-108[CrossRef][Medline].
|
| 24.
|
Magendzo, K.,
A. Shirvan,
C. Cultraro,
M. Srivastava,
H. B. Pollard, and A. L. Burns.
1991.
Alternative splicing of human synexin mRNA in brain, cardiac, and skeletal muscle alters the unique N-terminal domain.
J. Biol. Chem.
266:3228-3232[Abstract/Free Full Text].
|
| 25.
|
Meyers, M. B.,
T. S. Puri,
A. J. Chien,
T. Gao,
P. H. Hsu,
M. M. Hosey, and G. I. Fishman.
1998.
Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels.
J. Biol. Chem.
273:18930-18935[Abstract/Free Full Text].
|
| 26.
|
Meyers, M. B.,
T. S. Puri,
A. J. Chien,
T. Gao,
P. H. Hsu,
M. M. Hosey, and G. I. Fishman.
1998.
Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels.
J. Biol. Chem.
273:18930-18935.
|
| 27.
|
Meyers, M. B.,
C. Zamparelli,
D. Verzili,
A. P. Dicker,
T. J. Blanck, and E. Chiancone.
1995.
Calcium-dependent translocation of sorcin to membranes: functional relevance in contractile tissue.
FEBS Lett.
357:230-234[CrossRef][Medline].
|
| 28.
|
O'Farrell, P. H.
1975.
High resolution two-dimensional electrophoresis of proteins.
J. Biol. Chem.
250:4007-4021[Abstract/Free Full Text].
|
| 29.
|
Ohnishi, M.,
M. Tokuda,
T. Masaki,
T. Fujimura,
Y. Tai,
T. Itano,
H. Matsui,
T. Ishida,
R. Konishi,
J. Takahara, et al.
1995.
Involvement of annexin-I in glucose-induced insulin secretion in rat pancreatic islets.
Endocrinology
136:2421-2426[Abstract].
|
| 30.
|
Ohnishi, M.,
M. Tokuda,
T. Masaki,
T. Fujimura,
Y. Tai,
H. Matsui,
T. Itano,
T. Ishida,
J. Takahara,
R. Konishi, et al.
1994.
Changes in annexin I and II levels during the postnatal development of rat pancreatic islets.
J. Cell Sci.
107:2117-2125[Abstract].
|
| 31.
|
Olson, E. N.,
H. H. Arnold,
P. W. Rigby, and B. J. Wold.
1996.
Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4.
Cell
85:1-4[CrossRef][Medline].
|
| 32.
|
Piot, C.,
S. Lemaire,
B. Albat,
J. Seguin,
J. Nargeot, and S. Richard.
1996.
High frequency-induced upregulation of human cardiac calcium currents.
Circulation
93:120-128[Abstract/Free Full Text].
|
| 33.
|
Pollard, H. B.,
H. Caohuy,
A. P. Minton, and M. Srivastava.
1998.
Synexin (annexin 7) hypothesis for Ca2+/GTP-regulated exocytosis.
Adv. Pharmacol.
42:81-87.
|
| 34.
|
Prentki, M., and F. M. Matschinsky.
1987.
Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion.
Physiol. Rev.
67:1185-1248[Free Full Text].
|
| 35.
|
Raynal, P., and H. B. Pollard.
1994.
Annexins: the problem of assessing the biological role for a gene family.
Biochim. Biophys. Acta
1197:63-93[Medline].
|
| 36.
|
Russo-Marie, F.
1992.
Macrophages and the glucocorticoids.
J. Neuroimmunol.
40:281-286[CrossRef][Medline].
|
| 37.
|
Schwinger, R. H.,
K. Brixius,
U. Bavendiek,
S. Hoischen,
J. Muller-Ehmsen,
B. Bolck, and E. Erdmann.
1997.
Effect of cyclopiazonic acid on the force-frequency relationship in human nonfailing myocardium.
J. Pharmacol. Exp. Ther.
283:286-292[Abstract/Free Full Text].
|
| 38.
|
Selbert, S.,
P. Fischer,
D. Pongratz,
M. Stewart, and A. A. Noegel.
1995.
Expression and localization of annexin 7 (synexin) in muscle cells.
J. Cell Sci.
108:85-95[Abstract].
|
| 39.
|
Srivastava, M.,
I. Atwater,
M. Glasman,
X. Leighton,
G. Goping,
H. Caohuy,
G. Miller,
J. Pichel,
H. Westphal,
D. Mears,
E. Rojas, and H. B. Pollard.
1999.
Defects in inositol 1,4,5-trisphosphate receptor expression. Ca(2+) signaling, and insulin secretion in the Anxa7(+/ ) knockout mouse.
Proc. Natl. Acad. Sci. USA
96:13783-13788[Abstract/Free Full Text].
|
| 40.
|
Suzuki, H.,
H. Takano,
Y. Yamamoto,
T. Komuro,
M. Saito,
K. Kato, and K. Mikoshiba.
2000.
Properties of gastric smooth muscles obtained from mice which lack inositol trisphosphate receptor.
J. Physiol. (London)
525:105-111[Abstract/Free Full Text].
|
| 41.
|
Takeshima, H.,
S. Komazaki,
K. Hirose,
M. Nishi,
T. Noda, and M. Iino.
1998.
Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2.
EMBO J.
17:3309-3316[CrossRef][Medline].
|
| 42.
|
Ullrich, S., and C. B. Wollheim.
1988.
GTP-dependent inhibition of insulin secretion by epinephrine in permeabilized RINm5F cells. Lack of correlation between insulin secretion and cyclic AMP levels.
J. Biol. Chem.
263:8615-8620[Abstract/Free Full Text].
|
| 43.
|
Vallar, L.,
T. J. Biden, and C. B. Wollheim.
1987.
Guanine nucleotides induce Ca2+-independent insulin secretion from permeabilized RINm5F cells.
J. Biol. Chem.
262:5049-5056[Abstract/Free Full Text].
|
| 44.
|
Verzili, D.,
C. Zamparelli,
B. Mattei,
A. A. Noegel, and E. Chiancone.
2000.
The sorcin-annexin 7 calcium-dependent interaction requires the sorcin N-terminal domain.
FEBS Lett.
471:197-200[CrossRef][Medline].
|
| 45.
|
Viatchenko-Karpinski, S.,
B. K. Fleischmann,
Q. Liu,
H. Sauer,
O. Gryshchenko,
G. J. Ji, and J. Hescheler.
1999.
Intracellular Ca2+ oscillations drive spontaneous contractions in cardiomyocytes during early development.
Proc. Natl. Acad. Sci. USA
96:8259-8264[Abstract/Free Full Text].
|
| 46.
|
Witke, W.,
A. H. Sharpe,
J. H. Hartwig,
T. Azuma,
T. P. Stossel, and D. J. Kwiatkowski.
1995.
Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin.
Cell
81:41-51[CrossRef][Medline].
|
| 47.
|
Yoo, S. H., and C. J. Jeon.
2000.
Inositol 1,4,5-trisphosphate receptor/Ca2+ channel modulatory role of chromogranin A, a Ca2+ storage protein of secretory granules.
J. Biol. Chem.
275:15067-15073[Abstract/Free Full Text].
|
| 48.
|
Yoshizaki, H.,
S. Tanabe,
K. Arai,
A. Murakami,
Y. Wada,
M. Ohkuchi,
Y. Hashimoto, and M. Maki.
1992.
Effects of calphobindin II (annexin VI) on procoagulant and anticoagulant activities of cultured endothelial cells.
Chem. Pharm. Bull. (Tokyo)
40:1860-1863[Medline].
|
Molecular and Cellular Biology, July 2001, p. 4119-4128, Vol. 21, No. 13
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.13.4119-4128.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dobrowolski, R., Hertig, G., Lechner, H., Worsdorfer, P., Wulf, V., Dicke, N., Eckert, D., Bauer, R., Schorle, H., Willecke, K.
(2009). Loss of connexin43-mediated gap junctional coupling in the mesenchyme of limb buds leads to altered expression of morphogens in mice. Hum Mol Genet
18: 2899-2911
[Abstract]
[Full Text]
-
Dobrowolski, R., Sasse, P., Schrickel, J. W., Watkins, M., Kim, J.-S., Rackauskas, M., Troatz, C., Ghanem, A., Tiemann, K., Degen, J., Bukauskas, F. F., Civitelli, R., Lewalter, T., Fleischmann, B. K., Willecke, K.
(2008). The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Hum Mol Genet
17: 539-554
[Abstract]
[Full Text]
-
Schrickel, J. W., Brixius, K., Herr, C., Clemen, C. S., Sasse, P., Reetz, K., Grohe, C., Meyer, R., Tiemann, K., Schroder, R., Bloch, W., Nickenig, G., Fleischmann, B. K., Noegel, A. A., Schwinger, R. H.G., Lewalter, T.
(2007). Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice. Cardiovasc Res
76: 257-268
[Abstract]
[Full Text]
-
Sasse, P., Zhang, J., Cleemann, L., Morad, M., Hescheler, J., Fleischmann, B. K.
(2007). Intracellular Ca2+ Oscillations, a Potential Pacemaking Mechanism in Early Embryonic Heart Cells. JGP
130: 133-144
[Abstract]
[Full Text]
-
Reppel, M., Fleischmann, B. K., Reuter, H., Sasse, P., Schunkert, H., Hescheler, J.
(2007). Regulation of the Na+/Ca2+ exchanger (NCX) in the murine embryonic heart. Cardiovasc Res
75: 99-108
[Abstract]
[Full Text]
-
Nishioka, S., Aikawa, J.-i., Ida, M., Matsumoto, I., Street, M., Tsujimoto, M., Kojima-Aikawa, K.
(2007). Ligand-binding Activity and Expression Profile of Annexins in Caenorhabditis elegans. J Biochem
141: 47-55
[Abstract]
[Full Text]
-
Wang, W., Kirsch, T.
(2006). Annexin V/beta5 Integrin Interactions Regulate Apoptosis of Growth Plate Chondrocytes. J. Biol. Chem.
281: 30848-30856
[Abstract]
[Full Text]
-
Reppel, M., Sasse, P., Piekorz, R., Tang, M., Roell, W., Duan, Y., Kletke, A., Hescheler, J., Nurnberg, B., Fleischmann, B. K.
(2005). S100A1 Enhances the L-type Ca2+ Current in Embryonic Mouse and Neonatal Rat Ventricular Cardiomyocytes. J. Biol. Chem.
280: 36019-36028
[Abstract]
[Full Text]
-
Camors, E., Monceau, V., Charlemagne, D.
(2005). Annexins and Ca2+ handling in the heart. Cardiovasc Res
65: 793-802
[Abstract]
[Full Text]
-
Rescher, U., Gerke, V.
(2004). Annexins - unique membrane binding proteins with diverse functions. J. Cell Sci.
117: 2631-2639
[Abstract]
[Full Text]
-
Meyers, M. B., Fischer, A., Sun, Y.-J., Lopes, C. M. B., Rohacs, T., Nakamura, T. Y., Zhou, Y.-Y., Lee, P. C., Altschuld, R. A., McCune, S. A., Coetzee, W. A., Fishman, G. I.
(2003). Sorcin Regulates Excitation-Contraction Coupling in the Heart. J. Biol. Chem.
278: 28865-28871
[Abstract]
[Full Text]
-
Sanoudou, D., Haslett, J. N., Kho, A. T., Guo, S., Gazda, H. T., Greenberg, S. A., Lidov, H. G. W., Kohane, I. S., Kunkel, L. M., Beggs, A. H.
(2003). Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle. Proc. Natl. Acad. Sci. USA
100: 4666-4671
[Abstract]
[Full Text]
-
Antoons, G., Mubagwa, K., Nevelsteen, I., Sipido, K. R
(2002). Mechanisms underlying the frequency dependence of contraction and [Ca2+]i transients in mouse ventricular myocytes. J. Physiol.
543: 889-898
[Abstract]
[Full Text]
-
Yu, F., Finley, R. L. Jr., Raz, A., Kim, H.-R. C.
(2002). Galectin-3 Translocates to the Perinuclear Membranes and Inhibits Cytochrome c Release from the Mitochondria. A ROLE FOR SYNEXIN IN GALECTIN-3 TRANSLOCATION. J. Biol. Chem.
277: 15819-15827
[Abstract]
[Full Text]
-
Gerke, V., Moss, S. E.
(2002). Annexins: From Structure to Function. Physiol. Rev.
82: 331-371
[Abstract]
[Full Text]